New research is being presented at IAS 2013, the International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention, from June 30 to July 3 in Kuala Lumpur, Malaysia.
Meeting Highlights
HIV Patients Have High ESRD Rate
CD4 Count Linked to HIV Reservoir Level
HCV Reinfection High Among Gay Men With HIV
Repeat Use of Postexposure HIV Prophylaxis
Positive Outcomes With HIV Prevention Program
News From the Meeting
Kick, Kill, Contain – Researchers Examine Three Possible Steps in a Cure for HIV
Home Visits During Pregnancy Increase Number of Male Partners Tested for HIV
Stem Cell Transplant Leads to HIV Remission
German Researchers Report Case of “Functional Cure” After Very Early HIV Treatment
Cutting Dose of Efavirenz Safe, Effective in HIV
Nevirapine Toxicity May Be Linked to Race
How Can Most-at-Risk Populations Be Encouraged to Seek HIV Testing?
Turning Surveillance into Support for Men Who Have Sex With Men in Africa
Generic Competition Pushing Down HIV Drug Prices, but Patents Keep Newer Drugs Unaffordable
Experts Discuss Role of Drug Policy in HIV, Hepatitis and TB Epidemics
HIV Cure Has Long Way to Go Before the Clinic
High Positivity Rate and Good Linkage to Care at Barcelona Community Testing Project
AbbVie Interferon-Free Hepatitis C Combo Works Well With Reduced Ribavirin Dose
New HIV Treatment Guidelines to Cut Millions of Deaths
IAS 2013 Showcasing Cutting-Edge Research on HIV and AIDS
Malaysia Meeting at “Exciting Time for HIV”
More From the Meeting
Exhibition, Satellites, and Affiliated Independent Events
